Research before researching
To avoid waste of research, no new studies should be done without a systematic review of existing evidence. That argument has been made for 20 years, yet the lack of reference to a systematic review before designing new studies is still a problem.
Hand Lund, professor at the University of Southern Denmark joins us to explain why research before researching is still an issue.
Read the full analysis:
http://www.bmj.com/content/355/bmj.i5440 (Source: The BMJ Podcast)
Source: The BMJ Podcast - November 4, 2016 Category: General Medicine Authors: BMJ Group Source Type: podcasts
ESMO 2016: Press brief on the Danish model for cancer
Ulrik Lassen, MD, PhD of Copenhagen University Hospital, Copenhagen, Denmark talks about cancer in Denmark and the role of ESMO in this press briefing. Dr Lassen gives an overview of the Danish model ...
Author: VJOncology
Added: 10/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - October 18, 2016 Category: Cancer & Oncology Source Type: podcasts
In search of the Christmas spirit
Is the Christmas sprit divinely inspired, or does it reside within the body? Researchers from Denmark have tried to answer that age-old philosophical question with fMRI. Bryan Haddock, medical physicist at Rigshospitalet in Copenhagen joins us to explain what they found.
Read the full research:
http://www.bmj.com/cgi/doi/10.1136/bmj.h6266 (Source: The BMJ Podcast)
Source: The BMJ Podcast - December 15, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
In search of the Christmas spirit
Is the Christmas sprit divinely inspired, or does it reside within the body? Researchers from Denmark have tried to answer that age-old philosophical question with fMRI. Bryan Haddock, medical physicist at Rigshospitalet in Copenhagen joins us to explain what they found.
Read the full research:
http://www.bmj.com/cgi/doi/10.1136/bmj.h6266 (Source: The BMJ Podcast)
Source: The BMJ Podcast - December 15, 2015 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Being a human guinea pig
Drug development happens in stages – pre-clinical, phase I, II,
III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told?
Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on , and was... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 8, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Being a human guinea pig
Drug development happens in stages – pre-clinical, phase I, II,
III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told?
Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on, and was surprised at how little data had actually been collected, let alone shared – which has been detailed in an analysis article on thebmj.com
He talks to Helen Macdonald, analysis editor for the BMJ about his experience.
Read the analysis article:
http://www.bmj.com/content/349/bmj....
Source: The BMJ Podcast - January 8, 2015 Category: General Medicine Authors: BMJ Group Source Type: podcasts
" Bacterial Bouncers " -- The Discovery Files
A team of researchers in Denmark, at the University of California, Davis, and at UC Berkeley have identified a group of plant proteins that " shut the door " on bacteria that would otherwise infect the plant's leaves. The findings provide a better understanding of plants' immune systems and will likely find application in better protecting crops and horticultural plants against diseases. (Source: The Discovery Files)
Source: The Discovery Files - October 14, 2009 Category: Science Authors: National Science Foundation Source Type: podcasts
The Lancet: April 04, 2008
Doubts over the long-term safety of the HIV nucleoside reverse transcriptase inhibitor abacavir and the less commonly used antiretroviral drug didanosine are raised in a research Article. Both drugs were found to be associated with an increased risk of myocardial infarction. Jens Lundgren (University of Copenhagen, Denmark) discusses the study in this week's podcast. (Source: Listen to The Lancet)
Source: Listen to The Lancet - April 4, 2008 Category: General Medicine Authors: The Lancet Source Type: podcasts
The Lancet: November 16, 2007
Arne Astrup from the University of Copenhagen, Denmark, discusses a meta-analysis highlighting how the anti-obesity drug rimonabant is associated with an increased risk of depressive disorders. The meta-analysis pooled data from four randomised trials from the RIO (rimonabant in obesity) programme. (Source: Listen to The Lancet)
Source: Listen to The Lancet - November 16, 2007 Category: General Medicine Authors: The Lancet Source Type: podcasts
